LAVA Therapeutics N.V.
0.97
-0.01 (-1.02%)
At close: Jan 15, 2025, 3:57 PM
0.97
0.00%
After-hours Jan 15, 2025, 03:58 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue 6.77M 19.39M 5.35M 3.75M n/a
Cost of Revenue 3.48M n/a n/a 15.70M 8.35M
Gross Profit 3.29M 19.39M 5.35M -11.95M -8.35M
Operating Income -43.25M -34.84M -43.61M -14.67M -9.58M
Interest Income 2.97M 257.00K 625.00K 342.00K 86.00K
Pretax Income -41.70M -31.66M -42.20M -15.88M -9.69M
Net Income -41.97M -31.91M -42.35M -15.93M -9.69M
Selling & General & Admin 12.73M 14.12M 12.02M 2.72M 1.24M
Research & Development 33.81M 40.10M 36.95M 15.70M 8.35M
Other Expenses n/a n/a n/a n/a n/a
Operating Expenses 46.54M 51.31M 46.92M 3.59M 1.25M
Interest Expense n/a n/a 625.00K 342.00K n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 50.02M 51.31M 46.92M 19.29M 9.60M
Income Tax 279.00K 249.00K 157.00K 43.00K n/a
Shares Outstanding (Basic) 26.73M 25.92M 19.76M 25.35M 18.41M
Shares Outstanding (Diluted) 26.73M 25.92M 19.76M 25.35M 18.41M
EPS (Basic) -1.57 -1.23 -2.14 -39.9 -21.65
EPS (Diluted) -1.57 -1.23 -2.14 -39.9 -21.65
EBITDA -40.42M -30.88M -41.02M -14.65M -9.48M
Depreciation & Amortization 1.28M 504.00K 331.00K 213.00K 99.00K